Connect with us

Health

GSK says tests show Vir antibody drug works against Omicron

GlaxoSmithKline on Thursday said that a pre-clinical analysis of the antibody-based COVID-19 therapy it is developing with US partner Vir has indicated that the drug also works against the new Omicron variant.

Further tests will be carried out on the sotrovimab therapy to firm up the results, GSK said in a statement.

For all the latest headlines follow our Google News channel online or via the app.

Read more:

Moderna exec says company could have Omicron booster ready in March

UAE reports its first case of COVID-19 variant Omicron

Fauci: First US case of COVID-19 omicron variant identified

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Health

Tackling health impacts of climate change and scaling up digital climate action in the spotlight at COP28

Delegates at COP28 in Dubai on Saturday called for stronger and more resilient global health systems, which are indispensable to protecting populations from the negative impacts of climate change on health.

Continue Reading

Health

World AIDS Day celebrates communities working to end the disease

The leadership of communities affected by HIV has been vital in driving progress to end the epidemic, UN health agency WHO said on the eve of World AIDS Day, observed annually on 1 December.

Continue Reading

Health

Climate change risks upending global fight against malaria

Climate change and its impacts, particularly extreme weather and heatwaves, pose a “substantial risk” to progress being made to fight malaria, the UN World Health Organization (WHO) said on Thursday.

Continue Reading

Trending